Navigation Links
Occlutech Wins Confirmation of its Intellectual Property Position Versus AGA Medical Patent by AIPPI
Date:2/7/2008

JENA, Germany, February 7 /PRNewswire/ -- Occlutech GmbH, the leading European manufacturer of coronary occlusion devices today announced that it has obtained approval for its IP position in relation to patents held by AGA Medical Inc. from AIPPI, the European International Association for the Protection of Intellectual Property.

AIPPI is the world's leading non-government organization for research into and protection of intellectual property, and is a respected source for opinions and arbitration on IP matters such as patent interpretation and the use of IP in unfair competition.

In patent infringement litigation filed in Germany by AGA Medical Inc. in 2006, AGA argued and got the courts approval for a broad interpretation of its granted patent claims. During the original grant procedure, however, the Examiners of the European Patent Office did not accept the broad scope of the claims. This created significant reason for Occlutech to appeal the first instance district court's decision that Occlutech literally infringe the AGA patent in Germany and to initiate non-infringement proceedings in several other European countries. Occlutech asked AIPPI for an independent, clarifying opinion which now further supports Occlutech's position.

In a statement Robert Moszner, CEO of Occlutech GmbH said: "We are very pleased with the opinion of AIPPI. In addition to several expert opinions, it strongly supports our view that we are not infringing the patent brought forward by AGA Medical. We have developed a unique technology that is surrounded by its own strong intellectual property and we look forward to having our position confirmed in European and U.S. National courts."

Occlusion devices are used to treat structural heart disease, including structural heart defects and abnormalities such as Atrial Septal Defects, (ASD), and Patent Foramen Ovale (PFO) - an undesired channel between the hearts two atria that is present in up to 25% of the population - in a minimally invasive, non-surgical way. The market for PFO occluders in particular is expected to expand significantly as the link between PFO and strokes, as well as severe migraine, becomes increasingly well-documented.

Occlutech develops and manufactures a wide range of occluders that are sold under the Occlutech Figulla brand in over 40 countries in European and international markets. Clinical programs leading to regulatory approval in the US and Japan are also underway.

Contact:

Robert Moszner

e-mail:robert.moszner@occlutech.com

Phone: +49-3641-67-51-20

Susanne Goransson

e-mail: info@occlutech.info

Phone: +46-704336521


'/>"/>
SOURCE Occlutech GmbH
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. John Josef Molenda Joins Firms Intellectual Property Practice as Of Counsel
2. StemCor Systems Announces Acquisition of Intellectual Property to Enhance Bone Marrow Aspiration Platform
3. Written Statement of Kevin J. OConnor, Chairman of the Department of Justice Task Force on Intellectual Property, at the Senate Judiciary Committee Hearing on Intellectual Property Enforcement
4. Therap Services to Attend 2nd International Conference on Intellectual Disabilities/Mental Retardation as Gold Sponsor
5. Depression can foreshadow intellectual decline in older people
6. Mitchell Medical and Jopari Solutions Team up to Offer eBilling Compliance Services to Automobile Property & Casualty Insurance Carriers to Meet New Minnesota Requirements
7. ZIP codes and property values predict obesity rates
8. New Democracy Corps Battleground Poll of Swing Districts Finds Strong, Bi-Partisan Opposition to Cutting Medicare-Funded Nursing Home Care
9. LearnSomething Names Deborah Faucette to New Position of Senior Vice President of Sales and Marketing
10. Herman Miller, Inc., Announces Strategic Acquisition of Brandrud Furniture, Inc. to Expand Its Product Offerings and Competitive Position in the Healthcare Furnishings Sector
11. Start Licensing, Inc. Further Strengthens Position in Cloning Industry With New Patents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... CITY, Fla. (PRWEB) , ... October 12, 2017 , ... ... cold therapy products, announced today the introduction of an innovative new design of the ... multipurpose pad so you get maximum comfort while controlling your pain while using cold ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... for the 49th Congress of the International Society of Paediatric Oncology (SIOP) ... Center for Cancer and Blood Disorders at Children’s National, and Stephen P. ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... nation's first interactive health literacy software tool, and the Cancer Patient Education Network ... cancer patient education, today announce a new strategic alliance. , As CPEN’s ...
(Date:10/12/2017)... ... 2017 , ... Farm Forward joins Bon Appétit ... institutions in announcing the launch of the Leadership Circle , a program ... raised for food. , Founding members of the Leadership Circle also include Airbnb’s ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... Oct. 11, 2017  Caris Life Sciences ® , ... the promise of precision medicine, today announced that St. ... Precision Oncology Alliance™ (POA) as its 17 th ... St. Jude Crosson Cancer Institute will help develop standards ... of tumor profiling, making cancer treatment more precise and ...
(Date:10/7/2017)...   Provista, a proven leader in the ... purchasing power, today announced a new resource area on ... is the online home for case studies, articles ... news releases, slideshows and events. ... resources at their fingertips, viewers can also watch short ...
(Date:10/2/2017)... Oct. 2, 2017 Diplomat Pharmacy, Inc. (NYSE: ... Software and Consulting, LLC , and named its founder ... based in Tennessee , will operate ... expands EnvoyHealth,s service offerings for health care partners to ... "In an interoperable world, technology ...
Breaking Medicine Technology: